HKHisatomo Kowa

Hisatomo Kowa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hisatomo Kowa has a total of 121 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Associations of eye-tracking measures with global cognitive performance in community-dwelling older adults: an exploratory cross-sectional study

    by Yujia Zheng, Yuma Sonoda, Takeru Mukunoki, Mamoru Hiroe, Ryoko Kumagai, Minoru Nakayama, Takashi Nagamatsu, Hisatomo Kowa

  • Lower baseline cerebrospinal fluid amyloid-β 42 is associated with amyloid-related imaging abnormalities during real-world lecanemab treatment

    by Ryuichi Takahashi, Tetsuo Kashibayashi, Jun Fujita, Kohsuke Yoshida, Akira Hashiramoto, Hisatomo Kowa, Eiji Mizuta

    Amyloid-related imaging abnormalities (ARIA) are a safety concern during lecanemab treatment for early Alzheimer's disease. We examined baseline cerebrospinal fluid amyloid-β 42 (Aβ 42 ) in 97 lecanemab-treated patients; 11 developed ARIA. Aβ 42 was lower in ARIA cases than in non-ARIA cases (483.2 ± 108.6 versus 667.4 ± 185.4 pg/mL; p < 0.001). ROC analysis yielded an AUC of 0.806 (95% CI, 0.670–0.919). Aβ 40 was also lower, whereas the Aβ 42 /Aβ 40 ratio was not significantly different and tau biomarkers were not higher. Lower Aβ 42 was associated with subsequent ARIA, but the internally derived cutoff requires external validation.


  • Open Access

    Exploratory Integration of EEG Spectral Features and Gaze Variability for Mild Cognitive Impairment Discrimination

    by Takeru Mukunoki, Mamoru Hiroe, Minoru Nakayama, Yujia Zheng, Yuma Sonoda, Hisatomo Kowa, Takashi Nagamatsu

    Early detection of mild cognitive impairment (MCI) is an important challenge in aging societies. Electroencephalography (EEG) and eye-tracking have independently been explored as potential biomarkers; however, their integrative effects remain insufficiently examined. This exploratory study investigated whether combining EEG spectral features with gaze variability may provide complementary information for MCI discrimination. EEG signals were recorded using the 10–20 system, and spectral power features were extracted. We compared three models: (a) high-dimensional EEG features, (b) L1-regularized feature selection (LASSO), and (c) integration of the selected EEG features with gaze variability. Performance was evaluated using leave-one-out cross-validation and area under the ROC curve (AUC). Model (a) yielded limited discrimination (AUC = 0.52). Feature selection increased AUC (0.64), and additional integration of gaze variability further increased AUC (0.78). These preliminary findings suggest potential complementarity between neural and behavioral variability measures.

  • Inflammation-related miR-155-5p as an APOE ε4-modulated biomarker for amyloid pathology in mild cognitive impairment

    by Kohsuke Yoshida, Nonoka Saito, Ryuichi Takahashi, Shunsaburo Ando, Tetsuo Kashibayashi, Jun Fujita, Kazuki Takano, Hisatomo Kowa, Akira Hashiramoto

    Background: Alzheimer's disease (AD), the most common neurodegenerative cause of dementia, is defined by amyloid-β (Aβ) plaques and neurofibrillary tangles of hyperphosphorylated tau, while inflammatory processes are increasingly recognized as contributors to its pathogenesis. However, the clinical relevance of inflammation-related microRNAs (miRNAs) in AD remains unclear. Objective: To evaluate whether inflammation-related miRNAs in plasma and cerebrospinal fluid (CSF) are associated with AD pathology and apolipoprotein E ( APOE ) ε4 status in individuals with mild cognitive impairment (MCI). Methods: We investigated the expression of inflammation-related miR-125b, miR-146a, and miR-155-5p in plasma and CSF of individuals with MCI (N = 103), stratified by APOE ε4 status. Associations with established CSF biomarkers of AD pathology were assessed. In a subset receiving the anti-Aβ antibody lecanemab (N = 18), longitudinal changes in plasma inflammation-related microRNA levels were evaluated. Results: Plasma miR-155-5p levels in APOE ε4 non-carriers were associated with the CSF Aβ 42/40 ratio, whereas in ε4 carriers, CSF miR-155-5p levels correlated with phosphorylated tau 181 and total tau. miR-155-5p was the only inflammation-related miRNA showing consistent APOE ε4-dependent differential expression in both plasma and CSF. In the lecanemab-treated subset, plasma miR-155-5p increased significantly after 6 months and remained elevated at 12 months. Conclusions: miR-155-5p, an inflammation-related miRNA modulated by APOE ε4, is associated with AD-relevant pathological features and may provide complementary information at the MCI stage, with potential utility in monitoring biological responses to anti-Aβ therapy.


  • Open Access

    Factors Influencing Engagement in Work‐Related Activities Among People With Dementia or Mild Cognitive Impairment: A Cross‐Sectional Study

    by Erika Kamo, Yuma Sonoda, Takuma Yuri, Kayano Yotsumoto, Hisatomo Kowa

    Introduction: People with dementia or mild cognitive impairment (MCI) desire social connection and meaningful contribution, despite often being excluded from work‐related activities. The impact of engagement in work‐related activities on the mental well‐being of people with dementia or MCI remains underexplored. Objective: The aim of this study is to investigate the factors influencing engagement in work‐related activities among people with dementia or MCI. Design: Cross‐sectional study. Setting: Seven‐day care centers in Japan. Participants: Sixty‐three day care center members with dementia or MCI who had participated in work‐related activities for at least 6 months. Measures: Well‐being assessed by the World Health Organization‐Five Well‐Being Index (WHO‐5); engagement evaluated by the Assessment of Quality of Activities (A‐QOA), an occupational therapists–developed observational assessment tool; and confounders of engagement. Results: Among the 63 participants (age: median: 83 years, interquartile range [IQR]: 61, 94; Mini‐Mental State Examination‐Japanese score: median: 19 points, IQR: 4, 27), 74.6% were female. A significant correlation was observed between the WHO‐5 and A‐QOA ( ρ = 0.433, p < 0.001). Stepwise multiple regression analysis revealed a significant association between the A‐QOA and WHO‐5 ( β = 0.480, p < 0.001), frequency of participation ( β = 0.337, p = 0.003), and hearing loss–related social limitations ( β = 0.286, p = 0.01). Conclusion: Greater engagement in work‐related activities was associated with better well‐being, higher frequency of participation, and hearing loss–related social limitations. Implementation of and support for personalized work‐related activities, considering these factors for people with dementia or MCI, could enhance their engagement and promote their mental well‐being.

  • Open Access

    The Influence of Work‐Related Activities on Mental Well‐Being in Individuals With Dementia or Mild Cognitive Impairment: A Multicentre Cross‐Sectional Study in Japan

    by Erika Kamo, Yuma Sonoda, Takuma Yuri, Kayano Yotsumoto, Hisatomo Kowa

    Background: Social participation in work‐related activities can improve the mental well‐being of individuals with dementia or mild cognitive impairment (MCI). However, research on the effects of work‐related activities on the mental well‐being of individuals with dementia or MCI is limited. This study aimed to investigate the influence of participation in work‐related activities on mental well‐being and the associated factors in individuals with dementia or MCI. Methods: This was a multicentre cross‐sectional study. We administered questionnaires and measurements to participants who were users of a day care service and had dementia or MCI. We used the World Health Organization‐Five Well‐Being Index (WHO‐5) as the main outcome and its confounders. These data were compared between the work‐related activity and usual care groups, and multiple regression analysis was performed with WHO‐5 as the dependent variable and the presence or absence of participation in work‐related activities and WHO‐5 covariates as independent variables. Results: A total of 128 participants were compared between the two groups. The work‐related activity group exhibited better mental well‐being ( p < 0.001) than the usual care group. The same results were obtained after adjusting for the participants' backgrounds using propensity score matching. Multiple regression analysis identified participation in work‐related activities ( p < 0.001) and physical pain ( p < 0.05) as factors that potentially influence mental well‐being. Conclusions: Participation in work‐related activities positively influenced the mental well‐being of individuals with dementia or MCI. Longitudinal studies are needed to investigate the effects of work‐related activities on the mental well‐being of individuals with dementia or MCI.


  • Cognitive performance and blood biomarkers: Insights into their relationship and predicting high Amyloid Probability Score in cognitively impaired older adults

    by Thi Quynh Tho Chu, Kohei Morimoto, Hisatomo Kowa

    Background: Understanding associations between cognitive performance and blood biomarkers supports diagnosis and treatment of Alzheimer's disease (AD); however, this relationship remains unclear. Objective: Exploring associations between the Amyloid Probability Score (APS; PrecivityAD® blood test) and cognitive performance, and between Mini-Mental State Examination (MMSE) and Cogstate Brief Battery (CBB) in cognitively impaired older adults. Methods: Older adults aged ≥ 60 years with MMSE from 10 to 27, recruited from a cohort in Japan, were assessed with the CBB, and plasma biomarkers to calculate APS. We used Spearman correlation to explore relationships; receiver operating curves and cross-validation to identify the best model for predicting high APS. Results: Among 46 participants (mean age = 78.3 ± 5.9; mean MMSE = 20.3 ± 4.6), 39.1% did not complete at least one test in the CBB. Lower MMSE were observed in those who were non-completers. MMSE correlated with Detection (Psychomotor function), Identification (Attention), and their composite (r = 0.34−0.52; p < 0.05; 95%CI excluding null value). Higher APS was seen in those who did not complete the One Card Learning (OCL-visual learning and short-term memory). The best model for predicting High APS included OCL completion status, MMSE and Years of Education, achieving accuracy = 0.808 and kappa = 0.606 in participants with MMSE < 21. Conclusions: Our findings suggest a consideration of incompletion when using CBB in cognitively impaired older adults and a potential approach to differentiate High APS group among those with moderate to severe dementia based on visual learning and short-term memory, global cognition and education level.

  • Open Access

    Dementia detection by gaze using visuospatial memory task with CNN

    by Takeru Mukunoki, Junichi Nagasawa, Yuichi Nakata, Mamoru Hiroe, Yujia Zheng, Minoru Nakayama, Yuma Sonoda, Hisatomo Kowa, Takashi Nagamatsu


  • Open Access

    Effects of the Davos Alzheimer's Collaborative early detection of cognitive impairment program on clinician attitudes, engagement, and confidence

    by Tabasa Ozawa, Katherine J. Selzler, Daniel E. Ball, Amy Deckert, Tim MacLeod, Otelo Corrêa dos Santos Filho, Ishtar Govia, Janelle N. Robinson, Hisatomo Kowa, Mariana Lopez-Ortega, et al.


  • Open Access

    Tablet-based self assessment memory scale-revised (SAMS-R) evaluates memory functions for older adults

    by Hisatomo Kowa, Ryoko Kumagai, Yutaro Oki, Miki Imamura, Yuka Suzuki

    Background: The demand for more accurate and early diagnosis of mild cognitive impairment (MCI) patients due to Alzheimer’s disease (AD) has increased after disease-modifying drugs were launched. Among these needs, there is a requirement for tools that can easily assess the ability to recall memories, which changes early in the disease.Objectives: We established Self Assessment Memory Scale (SAMS) method before, which includes 8-picture recall test and 16-word recognition test. We adopted this method to software that can be operated on a tablet computer so that participants can perform the method independently. The purpose of this study was to validate this method.Design: Cross sectional research.Setting: Some of the participants were recruited from hospitals for patients diagnosed with AD or MCI. The others were recruited from three regional cohorts of healthy older adults.Participants: The total number of participants was 304 (20 of whom had AD or MCI), and the mean age was 71.2 years. 64% of the participants were women.Measurements: We used the logical memory subtest of the WMS-R as the standard for memory evaluation and assessed the relationship between this score and the SAMS score calculated by the software.Results: The 2nd SAMS score were higher than the 1st SAMS score in some participants, on the other hand, the intraclass correlation coefficient was good. Since the number of false recognition in the 16-word recognition test was higher in participants with lower LM II scores, we developed a new score to reflect the ratio of false recognition, SAMS-R, and we observed it has good correlation with LM II. The mean SAMS-R score decreased gradually after the age of 65 years, indicating that age-related changes in memory recall can be detected. The ROC curve analysis was conducted to evaluate the detectability to determine whether if the WMS-R LM II score is above or below 10, showing that the AUC was greater than 0.9.Conclusion: SAMS-R, which can be performed on a tablet literally by himself/herself independently, shows a high correlation with the WMS-R Logical Memory II score, and has the advantage of being performed in a short time without the need for a clinical psychologist or other personnel.